Case Study: Top Ten Pharmaceutical Company overhauls HCP targeting for an AML launch with Clarify Health

Top ten pharma’s oncology brand team uses precision analytics to overhaul their HCP target list for an upcoming drug launch

Top Ten Pharmaceutical Company’s oncology brand team was preparing to launch a second-line AML therapy, but its initial HCP target list was built on incomplete data that skewed toward outpatient and Medicare populations. To improve targeting for this new market, the team turned to Clarify Health and its Clarify Growth product to validate and refine the list.

Clarify Health used payer-complete longitudinal care journeys and precision analytics to identify eligible AML patients, attribute the right decision-making HCPs, and re-rank providers by opportunity. The result was a 33% larger target list, 159 newly identified high-value HCPs, and 590 HCPs reprioritized into more accurate deciles, helping the brand team reduce cost of sales and improve launch outreach.